Hologic (NSDQ:HOLX) said today it won expanded FDA 510(k) clearance for its subsidiary Cynosure’s SculpSure non-invasive body contouring laser, now cleared to treat the submental area. The new treatment indication expands the total for the company to 6, as the device is already cleared to treat the abdomen, flanks, back, inner and outer thighs, the Marlborough, […]
Medtech M&A: The 10 biggest deals so far in 2017
Over the past several years, the healthcare industry as a whole has experienced an abundance of mergers and acquisitions – major players are buying up their peers in deals ranging from millions to billions. The trend is continuing, and the healthcare playing field continues to be shaped by these mega-transactions. For the medical device industry, […]
Hologic’s Cynosure wins FDA expanded indications for SculpSure
Hologic (NSDQ:HOLX) said today its Cynosure subsidiary won expanded clearance from the FDA for its non-invasive SculpSure body contouring device. With the expanded indication, the SculpSure is now cleared for treatments of the back and inner and outer thighs, the Marlborough, Mass.-based company said. The device is already cleared for treatment of the abdomen and flanks. The […]
Hologic closes $1.7B Cynosure buy
Hologic (NSDQ:HOLX) said today that it closed its $1.65 billion acquisition of Cynosure Inc. (NSDQ:CYNO) and its portfolio of medical aesthetic products and devices. Marlborough, Mass.-based Hologic paid $66 per share for a total of 17 million shares of Class A stock, representing approximately 70.6% of the company’s outstanding shares. “We are pleased to complete our acquisition […]
Cynosure shareholders sue to block $1B Hologic merger
Cynosure Inc. (NSDQ:CYNO) shareholders last week filed a class action lawsuit to halt the company’s proposed $1.44 billion sale to Hologic (NSDQ:HOLX), alleging that Cynosure’s regulatory filing recommending the transaction is missing crucial information about the company’s financial projections and the process that led up to the deal. The complaint, filed in the U.S. District Court […]
Hologic to buy Cynosure in $1.65B deal
Hologic (NSDQ:HOLX) said today that it landed a deal to acquire Cynosure Inc. (NSDQ:CYNO) and its portfolio of medical aesthetics products for $1.65 billion. Marlborough, Mass.-based Hologic offered $66 per share – a 28% premium compared to Cynosure’s close yesterday. The transaction, which has a reported enterprise value of $1.44 billion, comes 1 day after Allergan […]
Cynosure wins Chinese FDA nod for Icon aesthetic system
Cynosure (NSDQ:CYNO) said today it won Chinese FDA clearance for its Icon aesthetic system, which is now cleared for multiple aesthetic indications. The system is now cleared in China for facial vessel and pigment clearance, wrinkle reduction, hair removal and scar and stretch mark treatment, the Westford, Mass.-based company said. “Cynosure was the 1st U.S. aesthetic laser […]
Integrated Endoscopy names Sharp as prez & CEO | Personnel Moves November 15, 2016
Integrated Endoscopy said today it tapped Brad Sharp as its new prez & CEO, as well as joining the company’s board. The company said it is making the move with Sharp in preparation of the launch of its Nevis single-use arthroscope, which is slated for early 2017. The company said it also named Rob Cripe […]
Novartis pharma head Epstein steps away, most recent in string of top-level turnovers | Personnel Moves, May 27, 2015
Novartis pharma head Epstein steps away, most recent loss in string of top-level turnovers Novartis (NYSE:NVS) is facing an upheaval in its top management, seeing 7 departures over the last 5 months as shares fell 25% since last July. Last week, Novartis pharmaceuticals head David Epstein quit as his division was split up. Earlier in the month, U.S. […]
FDA clears next-gen tattoo removal laser from Cynosure
Cynosure (NSDQ:CYNO) said today it won FDA 510(k) clearance for its 1064 nm PicoSure laser delivery system designed for tattoo removal. The next-gen laser delivery system has improved multi-wavelength laser technology designed to remove the “full color spectrum of tattoo inks” in less treatments than previous versions, the Westford, Mass.-based company said. “PicoSure is widely […]
Tattoo removal: FDA clears Cynosure’s 532 nm laser system
The FDA has cleared Cynosure’s (NSDQ:CYNO) 532 nm Laser Delivery System for its PicoSure tattoo-removal technology platform.
Cynosure said the regulatory win will enable the PicoSure system to remove all colors of ink in fewer sessions.
- 1
- 2
- 3
- …
- 6
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+